Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05224986 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lifestyle Patterns and Glycemic Control

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing Final enrollment: 15 participants (planned 34) · Completion pushed from Jul 31, 2026 to Dec 31, 2026 · Eligibility criteria expanded, about 16 words · 2 more Show 5 more changesShow less
    • Final enrollment: 15 participants (planned 34)
    • Completion pushed from Jul 31, 2026 to Dec 31, 2026
    • Eligibility criteria expanded, about 16 words
    • Secondary endpoints: details revised at 1 of 7 entries
    • Site details revised
  2. Primary completion date: Dec 31, 2025 to Jun 30, 2026 Completion date: Jun 1, 2026 to Jul 31, 2026v14 Show 1 more changeShow less
    • Completion date: Jun 1, 2026 to Jul 31, 2026
  3. Primary completion date: Jun 1, 2025 to Dec 31, 2025 Completion date: Jun 1, 2025 to Jun 1, 2026v13 Show 1 more changeShow less
    • Completion date: Jun 1, 2025 to Jun 1, 2026
  4. Re-verified, no change to tracked fieldsv12
  5. Primary and study completion dates: Jun 1, 2024 to Jun 1, 2025v11
Show 9 earlier versionsHide 9 earlier versions
  1. Eligibility criteria revisedv10 See this version in full on ClinicalTrials.gov ↗
  2. Secondary endpoints: details revised at 2 of 7 entriesv9
  3. Secondary endpoints: details revised at 2 of 7 entriesv8
  4. Secondary endpoints revised (7)v7 See this version in full on ClinicalTrials.gov ↗
  5. Eligibility criteria shortened, about 10 wordsv6 See this version in full on ClinicalTrials.gov ↗
  6. Interventions: Fixed Sleep (Behavioral) to Fixed Schedule (Behavioral) Study description shortened, about 27 wordsv5 Show 1 more changeShow less
    • Study description shortened, about 27 words

    See this version in full on ClinicalTrials.gov ↗

  7. Primary and study completion dates: Jan 15, 2023 to Jun 1, 2024 Eligibility criteria shortened, about 1 wordv4 Show 1 more changeShow less
    • Eligibility criteria shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  8. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Feb 2022 to Jan 19, 2022 · Secondary endpoints: 3 to 7 · Site details revised · 1 morev3 Show 4 more changesShow less
    • Start date changed from estimate of Feb 2022 to Jan 19, 2022
    • Secondary endpoints: 3 to 7
    • Site details revised
    • Study title shortened, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  9. Secondary endpoints: details revised at 1 of 3 entriesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Columbia University
302 trials monitored
See 23 trials at risk
Diabetes
4,286 trials monitored
See 187 trials at risk
The goal of the proposed study is to evaluate the feasibility and initial efficacy of stabilizing lifestyle behaviors to improve glucose control and body composition in patients with pre-diabetes. The investigator proposes that following stable lifestyle behaviors will improve patients' glucose control, body composition, and liver fat. The results from this study has the potential to impact clinical practice and patient care.
Trial Details
NCT Number NCT05224986
Lead Sponsor Columbia University
Collaborators: Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Pre-diabetes
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov